Clinical Performance Evaluation of AMH Assay
Public ClinicalTrials.gov record NCT03131388. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Access AMH Assay is an in vitro diagnostic assay intended as an aid for fertility assessment. The purpose of the study is to evaluate the clinical performance of the Access AMH Assay in the intended use population.
Study identification
- NCT ID
- NCT03131388
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 277 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 45 Years
- Sex
- Female
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2016
- Primary completion
- Apr 29, 2018
- Completion
- Apr 29, 2018
- Last update posted
- Jul 12, 2018
2016 – 2018
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| BRI | Phoenix | Arizona | 85258 | — |
| Stanford | Palo Alto | California | 94305 | — |
| FSMG | San Diego | California | 92123 | — |
| RAD | Newark | Delaware | 19713 | — |
| WRMG | Clearwater | Florida | 33759 | — |
| Vios Fertility | Swansea | Illinois | 62226 | — |
| BIVF | Waltham | Massachusetts | 02451 | — |
| Mainline Fertility | Bryn Mawr | Pennsylvania | 19010 | — |
| Univ Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| CARE | Dallas | Texas | 76022 | — |
| CORM | Webster | Texas | 77598 | — |
| PNWF | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03131388, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 12, 2018 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03131388 live on ClinicalTrials.gov.